These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 12453880)
1. In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo. Schuch G; Machluf M; Bartsch G; Nomi M; Richard H; Atala A; Soker S Blood; 2002 Dec; 100(13):4622-8. PubMed ID: 12453880 [TBL] [Abstract][Full Text] [Related]
2. The protein tyrosine kinase inhibitor SU5614 inhibits VEGF-induced endothelial cell sprouting and induces growth arrest and apoptosis by inhibition of c-kit in AML cells. Spiekermann K; Faber F; Voswinckel R; Hiddemann W Exp Hematol; 2002 Jul; 30(7):767-73. PubMed ID: 12135675 [TBL] [Abstract][Full Text] [Related]
3. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer. Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677 [TBL] [Abstract][Full Text] [Related]
4. Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis. Yen L; You XL; Al Moustafa AE; Batist G; Hynes NE; Mader S; Meloche S; Alaoui-Jamali MA Oncogene; 2000 Jul; 19(31):3460-9. PubMed ID: 10918604 [TBL] [Abstract][Full Text] [Related]
5. p73 Overexpression increases VEGF and reduces thrombospondin-1 production: implications for tumor angiogenesis. Vikhanskaya F; Bani MR; Borsotti P; Ghilardi C; Ceruti R; Ghisleni G; Marabese M; Giavazzi R; Broggini M; Taraboletti G Oncogene; 2001 Nov; 20(50):7293-300. PubMed ID: 11704858 [TBL] [Abstract][Full Text] [Related]
6. [Expression of vascular endothelial growth factor in bone marrow cells of patients with acute myeloid leukemia]. Xu D; Meng FY; Zhang Y Di Yi Jun Yi Da Xue Xue Bao; 2002 Apr; 22(4):357-9. PubMed ID: 12422902 [TBL] [Abstract][Full Text] [Related]
7. Human myeloid and lymphoid malignancies in the non-obese diabetic/severe combined immunodeficiency mouse model: frequency of apoptotic cells in solid tumors and efficiency and speed of engraftment correlate with vascular endothelial growth factor production. Fusetti L; Pruneri G; Gobbi A; Rabascio C; Carboni N; Peccatori F; Martinelli G; Bertolini F Cancer Res; 2000 May; 60(9):2527-34. PubMed ID: 10811135 [TBL] [Abstract][Full Text] [Related]
8. Expression of endothelial cell-associated molecules in AML cells. Watarai M; Miwa H; Shikami M; Sugamura K; Wakabayashi M; Satoh A; Tsuboi K; Imamura A; Mihara H; Katoh Y; Kita K; Nitta M Leukemia; 2002 Jan; 16(1):112-9. PubMed ID: 11840270 [TBL] [Abstract][Full Text] [Related]
12. Recombinant adenovirus expressing wild-type p53 is antiangiogenic: a proposed mechanism for bystander effect. Nishizaki M; Fujiwara T; Tanida T; Hizuta A; Nishimori H; Tokino T; Nakamura Y; Bouvet M; Roth JA; Tanaka N Clin Cancer Res; 1999 May; 5(5):1015-23. PubMed ID: 10353734 [TBL] [Abstract][Full Text] [Related]
13. Increased bone marrow vascularization in patients with acute myeloid leukaemia: a possible role for vascular endothelial growth factor. de Bont ES; Rosati S; Jacobs S; Kamps WA; Vellenga E Br J Haematol; 2001 May; 113(2):296-304. PubMed ID: 11380392 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia. Padró T; Bieker R; Ruiz S; Steins M; Retzlaff S; Bürger H; Büchner T; Kessler T; Herrera F; Kienast J; Müller-Tidow C; Serve H; Berdel WE; Mesters RM Leukemia; 2002 Jul; 16(7):1302-10. PubMed ID: 12094254 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of breast carcinoma and trophoblast cell invasiveness by vascular endothelial growth factor. Fitzpatrick TE; Lash GE; Yanaihara A; Charnock-Jones DS; Macdonald-Goodfellow SK; Graham CH Exp Cell Res; 2003 Feb; 283(2):247-55. PubMed ID: 12581744 [TBL] [Abstract][Full Text] [Related]
16. A novel peptide isolated from a phage display library inhibits tumor growth and metastasis by blocking the binding of vascular endothelial growth factor to its kinase domain receptor. Hetian L; Ping A; Shumei S; Xiaoying L; Luowen H; Jian W; Lin M; Meisheng L; Junshan Y; Chengchao S J Biol Chem; 2002 Nov; 277(45):43137-42. PubMed ID: 12183450 [TBL] [Abstract][Full Text] [Related]
17. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels. Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091 [TBL] [Abstract][Full Text] [Related]
18. Induction of neuropilin-1 and vascular endothelial growth factor by epidermal growth factor in human gastric cancer cells. Akagi M; Kawaguchi M; Liu W; McCarty MF; Takeda A; Fan F; Stoeltzing O; Parikh AA; Jung YD; Bucana CD; Mansfield PF; Hicklin DJ; Ellis LM Br J Cancer; 2003 Mar; 88(5):796-802. PubMed ID: 12618892 [TBL] [Abstract][Full Text] [Related]
19. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF. Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of human leukemia in an animal model with human antibodies directed against vascular endothelial growth factor receptor 2. Correlation between antibody affinity and biological activity. Zhu Z; Hattori K; Zhang H; Jimenez X; Ludwig DL; Dias S; Kussie P; Koo H; Kim HJ; Lu D; Liu M; Tejada R; Friedrich M; Bohlen P; Witte L; Rafii S Leukemia; 2003 Mar; 17(3):604-11. PubMed ID: 12646950 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]